Our Promise to You

Guaranteed product quality, expert customer support

Our Promise to You

ONLINE INQUIRY

NRS-1

Cat.No.: CSC-C6406J

Species: Human

Morphology: other

Culture Properties: Adherent cells

  • Specification
  • Q & A
  • Customer Review
Cat.No.
CSC-C6406J
Description
Human rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it.
Species
Human
Tissue of Origin
left forearm
Recommended Medium
MEM ALPHA + 10% h.i. FBS
Culture Properties
Adherent cells
Morphology
other
Storage and Shipping
Ship in dry ice.
Store in liquid nitrogen.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.
What are some promising emerging therapies for sarcoma cells?

Emerging therapies for sarcoma cells include immune checkpoint inhibitors, gene therapies, and molecularly targeted drugs designed to inhibit specific genetic mutations prevalent in some sarcoma subtypes.

Ask a Question

Average Rating: 4.0    |    1 Scientist has reviewed this product

No contamination

Cells from Creative Bioarray are not contaminated, so we can get reliable and reproducible results.

05 June 2023


Ease of use

After sales services

Value for money


Write your own review

  • You May Also Need

For research use only. Not for any other purpose.